EQL Pharma AB
Develops and sells niche generic and specialty medicines, primarily in Nordic markets.
EQL | ST
Overview
Corporate Details
- ISIN(s):
- SE0005497732
- LEI:
- 549300Q8B2D2AE8GCW21
- Country:
- Sweden
- Address:
- Stortorget 1, 222 23 Lund
- Website:
- https://eqlpharma.com/en/
- Sector:
- Manufacturing
Description
EQL Pharma AB is a pharmaceutical company that develops, markets, and sells generic and specialty medicines. The company's strategy centers on identifying and developing "niche generics," which are medically equivalent to originator drugs but face limited competition after patent expiration. Its business operations also include specialty pharmaceuticals and the parallel import of medicines. EQL Pharma emphasizes cost-efficiency and collaborates with a global network of development partners. The company serves pharmacies and hospitals, primarily in the Nordic markets, maintaining a portfolio of marketed products while cultivating an extensive pipeline of new medicines.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-12-04 10:00 |
EQL Pharma rekryterar Anne D Jensen som ny försäljningschef (CSO) och Carl Lind…
|
Swedish | 180.0 KB | ||
| 2025-12-04 10:00 |
EQL Pharma recruits Anne D Jensen as new Chief Sales Officer (CSO) and Carl Lin…
|
English | 179.2 KB | ||
| 2025-12-03 14:37 |
EQL Pharma recruits Allan Sylvest Aasberg as new Chief Financial Officer (CFO)
|
English | 176.9 KB | ||
| 2025-12-03 14:37 |
EQL Pharma rekryterar Allan Sylvest Aasberg som ny Chief Financial Officer (CFO)
|
Swedish | 176.7 KB | ||
| 2025-11-17 13:58 |
EQL Pharma AB (publ) publishes prospectus and applies for admission to trading …
|
English | 537.2 KB | ||
| 2025-11-05 07:00 | Swedish | 1.7 MB | |||
| 2025-11-05 07:00 | English | 1.6 MB | |||
| 2025-10-06 15:08 |
EQL Pharma i process att rekrytera ny Chief Commercial Officer (CCO)
|
Swedish | 332.6 KB | ||
| 2025-10-06 15:08 |
EQL Pharma in process of recruiting new Chief Commercial Officer (CCO)
|
English | 172.7 KB | ||
| 2025-09-30 10:00 |
Ändring av antalet aktier och röster i EQL Pharma AB
|
Swedish | 167.4 KB | ||
| 2025-09-30 10:00 |
Change in number of shares and votes in EQL Pharma AB
|
English | 167.5 KB | ||
| 2025-09-22 22:35 |
Delivery delays mean that the second quarter and thus the full year 2025/26 wil…
|
English | 224.7 KB | ||
| 2025-09-22 22:35 |
Leveransförseningar gör att andra kvartalet och därmed helåret 2025/26 blir sva…
|
Swedish | 150.7 KB | ||
| 2025-08-21 18:00 |
Kommuniké från årsstämma i EQL Pharma AB den 21 augusti 2025
|
Swedish | 258.1 KB | ||
| 2025-08-21 18:00 |
Bulletin from the annual general meeting in EQL Pharma AB on 21 August 2025
|
English | 259.5 KB |
Automate Your Workflow. Get a real-time feed of all EQL Pharma AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for EQL Pharma AB
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for EQL Pharma AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-02-17 | christer fåhraeus | Other | Sell | 100,000 | 8,620,000.00 SEK |
Peer Companies
